Patrick Horn - Jul 22, 2021 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
Chief Medical Officer
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Jul 22, 2021
Transactions value $
-$3,072
Form type
4
Date filed
7/26/2021, 04:06 PM
Next filing
Oct 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale -$3.07K -90 -0.72% $34.13 12.5K Jul 22, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 5,075 shares of common stock and 7,375 restricted stock units. Includes 647 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on May 31, 2021.